Medline Inc. (MDLN)
NASDAQ
34.68
+0.42 (+1.23%)
Closed
Aug 24, 2026
Day's Range
34.1835.05
52 wk Range
32.4850.88
Financial Statements - MDLN - Medline Inc.
Revenue
28.43B
Net Income
1.15BNet Margin 4.1%
EBITDA
3.15B
Free Cash Flow
1.29B
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 28.43B | - |
| Cost of Goods | 20.91B | - |
| Gross Profit | 7.51B | - |
 Operating Expense | - | - |
| Operating Income | 2.21B | - |
| Non-Operating Interest | - | - |
| Other Income Expense | -152M | - |
| Pre Tax Income | 1.24B | - |
| Income Tax | 91M | - |
| Net Income | 1.15B | - |
| EPS Basic | 1.42734 | 0.656586 |
| EPS Diluted | 1.42734 | 0.656586 |
| Basic Shares Outstanding | 812M | 1.82B |
| Diluted Shares Outstanding | 812M | 1.82B |
| Ebit | 2.06B | - |
| Ebitda | 3.15B | - |
| Net Income Continuous Operations | 1.15B | - |
| Minority Interests | 2M | 0 |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
